Literature DB >> 21044750

Serum adiponectin and vaspin levels in rheumatoid arthritis.

Metin Ozgen1, Suleyman Serdar Koca, Necati Dagli, Mehmet Balin, Bilal Ustundag, Ahmet Isik.   

Abstract

BACKGROUND AND AIMS: The risks of insulin resistance and accelerated atherosclerosis are increased in chronic inflammatory diseases including rheumatoid arthritis (RA). Adipo-(cyto)kines are associated with insulin resistance, atherosclerosis and inflammation. This study aimed to determine serum adiponectin and vaspin levels and their associations with the predictors of atherosclerosis in RA and Behcet's disease (BD).
METHODS: The study involved 56 patients with RA, 37 patients with BD, and 29 healthy controls (HC). Serum adiponectin and vaspin levels, homeostasis model assessment for insulin resistance (HOMA-IR) index, and common carotid intima-media thickness (IMT) were determined.
RESULTS: Serum adiponectin levels in both patient groups and serum vaspin level in only the RA group were higher, whereas serum vaspin level was lower in the active BD subgroup, compared to the HC group. However, adiponectin and vaspin levels were correlated with neither HOMA-IR index nor IMT in the RA group. Adiponectin level was correlated with DAS-28 and IL-6 level in the RA group, and it was higher in the active BD subgroup than in the inactive BD subgroup and the HC group.
CONCLUSIONS: Adiponectin and vaspin levels are higher in RA but associated with neither HOMA-IR index nor IMT. Adiponectin is related with disease activity remarks in RA and BD. Therefore, it may be suggested that adiponectin may be involved in the regulation of inflammatory responses in inflammatory diseases. Moreover, in contrast to in RA, vaspin level declines in active BD, and these results suggest that different chronic inflammatory diseases exert different influences on either adipokines.
Copyright © 2010 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044750     DOI: 10.1016/j.arcmed.2010.08.012

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  23 in total

Review 1.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

2.  Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis.

Authors:  Jia-Peng Bao; Li-Feng Jiang; Wei-Ping Chen; Peng-Fei Hu; Li-Dong Wu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 3.  'Metabolically healthy obesity': origins and implications.

Authors:  Gerald V Denis; Martin S Obin
Journal:  Mol Aspects Med       Date:  2012-10-13

Review 4.  What's new in our understanding of the role of adipokines in rheumatic diseases?

Authors:  Rodolfo Gómez; Javier Conde; Morena Scotece; Juan Jesus Gómez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

5.  Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals.

Authors:  Sajjad Moradi; Khadijeh Mirzaei; Ahmed Abdulahi Abdurahman; Seyed Ali Keshavarz; Arash Hossein-Nezhad
Journal:  Eur J Nutr       Date:  2015-06-10       Impact factor: 5.614

6.  High serum vaspin concentrations in patients with ulcerative colitis.

Authors:  Tomohito Morisaki; Fuminao Takeshima; Hiroko Fukuda; Kayoko Matsushima; Yuko Akazawa; Naoyuki Yamaguchi; Ken Ohnita; Hajime Isomoto; Hiroaki Takeshita; Terumitsu Sawai; Fumihiko Fujita; Kazuhiko Nakao
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

Review 7.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

8.  Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk.

Authors:  Patrick H Dessein; Gavin R Norton; Margaret Badenhorst; Angela J Woodiwiss; Ahmed Solomon
Journal:  Mediators Inflamm       Date:  2013-04-03       Impact factor: 4.711

9.  Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis.

Authors:  Sergey P Oranskiy; Ludmila N Yeliseyeva; Anna V Tsanaeva; Nadezhda V Zaytseva
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

Review 10.  The role of adipokines in connective tissue diseases.

Authors:  Robert Krysiak; Gabriela Handzlik-Orlik; Boguslaw Okopien
Journal:  Eur J Nutr       Date:  2012-05-15       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.